Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Jan 15 2025
Business
Jan 15 2025
3 min read

Press Release Jan 15 2025

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 15, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg".

View Attachment